Approved
consistent with clarification in FDA memo of 2-9-03.
Inventory as of this Action
Requested
Previously Approved
03/31/2006
03/31/2006
02/28/2003
3,103
0
1,985
42,760
0
24,986
0
0
0
The guidance provides information on
how the agency will interpret and apply section 119(a) of the
Modernization Act, specific PDUFA goals for the management of
meetings associated with the review of human drug applications for
PUFA products, and provisions of existing regulations describing
certain meetings (Secs. 312.47 and 281.82 (21 CFR 312.47 and
312.82)). The gudiance describes two collections of information:
The submission of a meeting request containing certain information
and the submission of an information package in advance of the
formal meeting. Agency regulations at Sec.
312.47(b)(1)(ii),...
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.